The companies said the name is derived from the Latinwords via, meaning path, and tris, meaning three, to signify the company’s three core goals: expanding access to medicines, leading by innovating to meet patient needs and being a trusted partner for the healthcare community.
The companies have not yet announced where Viatris will be headquartered, besides that it will be in the U.S., according to the Pittsburgh Post-Gazette.
Mylan and Pfizer said more information on Viatris, including the company’s full executive management team, board of directors, stock symbol and logo will be announced at a later date.
The merger is expected to be finalized in mid-2020.
Read the full news release here.
More articles on pharmacy:
Endo CEO to retire
Trump administration sues Gilead
CVS to close 22 ‘underperforming’ stores
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
